BETAEVAL - The New BETACONNECT Auto-injector: Adherence and EVALuation of MS Patients Treated With Betaferon
Phase of Trial: Phase IV
Latest Information Update: 24 Oct 2017
Price : $35 *
At a glance
- Drugs Interferon beta-1b (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Acronyms BETAEVAL
- Sponsors Bayer
- 17 Sep 2016 Interim results (n=443) presented at the 32nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis
- 08 Jun 2016 Status changed from recruiting to completed.
- 27 Jun 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.